Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma

Figure 6 Expression of FABP5 correlates with PLK1 and BIRC5 expression in pan cancer and liver cancer. A: Expression of FABP5 and other FABP family members as well as several highlighted genes CCNB1, TP53, BIRC5 and PLK1 in each cancer type using GEPIA2 portal; B and C: FABP5 expression positively correlated with expression of BIRC5 at pan cancer (B) and liver cancer (C); D and E: FABP5 expression positively correlated with expression of PLK1 at pan cancer (D) and liver cancer (E); F and G: BIRC5 expression positively correlated with expression of PLK1 at pan cancer (F) and liver cancer (G). P values show the statistical significance of the correlation; R values show the correlation coefficient.